Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x100px

Person › Details

Douglas VanOort (NeoGenomics Inc. (Nasdaq: NEO))

VanOort, Douglas (NeoGenomics 201703 CEO)

	Organisation	NeoGenomics Inc. (Nasdaq: NEO)
	Group	NeoGenomics (Group)

Record changed: 2017-04-09

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Douglas VanOort

[1] Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL....
[2] Definiens AG. (3/13/17). "Press Release: NeoGenomics and Definiens Enter into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing". Fort Myers, FL....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)